OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $437,040.00 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Jennifer Pritzker sold 18,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $24.28, for a total transaction of $437,040.00. Following the transaction, the insider owned 6,863,464 shares of the company’s stock, valued at approximately $166,644,905.92. This trade represents a 0.26% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

OrthoPediatrics Price Performance

Shares of KIDS opened at $23.65 on Friday. The company has a market cap of $617.50 million, a price-to-earnings ratio of -14.08 and a beta of 0.98. OrthoPediatrics Corp. has a twelve month low of $14.42 and a twelve month high of $26.74. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28. The company has a 50 day moving average of $21.41 and a two-hundred day moving average of $18.66.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. The business had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. As a group, analysts predict that OrthoPediatrics Corp. will post -1.14 earnings per share for the current fiscal year.

Institutional Trading of OrthoPediatrics

Large investors have recently added to or reduced their stakes in the company. Russell Investments Group Ltd. raised its stake in shares of OrthoPediatrics by 433.1% in the third quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after purchasing an additional 1,139 shares during the last quarter. Legal & General Group Plc purchased a new stake in OrthoPediatrics in the second quarter valued at approximately $34,000. Northwestern Mutual Wealth Management Co. boosted its position in OrthoPediatrics by 5,226.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after buying an additional 2,561 shares during the last quarter. Caption Management LLC acquired a new position in OrthoPediatrics in the 3rd quarter worth approximately $54,000. Finally, BNP Paribas Financial Markets raised its position in OrthoPediatrics by 60.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after buying an additional 1,235 shares during the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on KIDS. TD Cowen reaffirmed a “buy” rating on shares of OrthoPediatrics in a research report on Monday, June 15th. Weiss Ratings upgraded OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. Piper Sandler restated an “overweight” rating and set a $25.00 price objective (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. BTIG Research increased their price objective on shares of OrthoPediatrics from $24.00 to $29.00 and gave the company a “buy” rating in a research report on Thursday, August 20th. Finally, Needham & Company LLC increased their price objective on shares of OrthoPediatrics from $30.00 to $35.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Nine research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, OrthoPediatrics currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.44.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.